MMP9 and neoplasm: As shown in Fig. 4e, f, the in-situ expression of Ki67, p53, and epithelial–mesenchymal transition (EMT)-related markers like MMP9, fibronectin, and vimentin were significantly lower in the metastatic nodules and primary tumor tissues of the SNORA42-knockdown versus the control group.